FOXM1 and esophageal cancer: In line with our previous results, esophageal cancer cells treated with paclitaxel (Taxol) at sublethal concentrations showed significantly higher levels of cellular FOXM1 protein without showing prominent cytotoxic effects (Fig. 5G).